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Abstract. 
 
We have developed a biochemical approach 
for identifying the components of cortical actin assem-
bly sites in polarized yeast cells, based on a permeabi-
lized cell assay that we established for actin assembly in 
vitro. Previous analysis indicated that an activity associ-
ated with the cell cortex promotes actin polymerization 
in the bud. After inactivation by a chemical treatment, 
this activity can be reconstituted back to the permeabi-
lized cells from a cytoplasmic extract. Fractionation of 
the extract revealed that the reconstitution depends on 
two sequentially acting protein factors. Bee1, a cortical 
actin cytoskeletal protein with sequence homology to 
Wiskott-Aldrich syndrome protein, is required for the 
first step of the reconstitution. This finding, together 
with the severe defects in actin organization associated 
with the 
 
bee1
 
 null mutation, indicates that Bee1 protein 
plays a direct role in controlling actin polymerization at 
the cell cortex. The factor that acts in the second step of 
the reconstitution has been identified by conventional 
chromatography. It is composed of a novel protein, 
Pca1. Sequence analysis suggests that Pca1 has the po-
tential to interact with SH3 domain-containing proteins 
and phospholipids.
 
T
 
he
 
 cortical actin cytoskeleton plays a profound role
in cell surface growth and shape definition. The di-
versity of morphogenetic processes requires that
the machinery that controls cortical actin dynamics must
be able to respond to intricate cellular signals, to localize
to specific regions of the cell cortex, and to assemble actin
filaments into defined super-structures. This requirement
implies that the sites of actin assembly are likely to be
composed of complex sets of proteins, including not only
the structural proteins that modulate the dynamic behav-
ior of actin filaments, but also proteins that could integrate
the signals from various regulatory cascades.
The complexity of signaling networks and cytoskeletal
architecture have made it difficult to define the exact
mechanisms of actin assembly at the cell cortex. In this re-
gard, the genetic tractability and relative simplicity of yeast
cells present advantages for studying cortical actin assem-
bly. Genetic analysis in yeast has been fruitful in identify-
ing a number of genes that encode actin cytoskeletal com-
ponents, and in revealing the in vivo processes in which
actin itself and some of the classical actin-binding proteins
are involved (for review see Welch et al., 1994). As a first
step toward integrating biochemical and genetic studies of
the mechanism of actin assembly, we developed an assay
for cortical actin assembly in permeabilized yeast cells (Li
et al., 1995). This assay is based on a permeabilization
method that involves rupturing the cell wall by rapid freez-
ing and permeabilization of the membrane by treatment
with saponin. Cells thus permeabilized have the ability to
incorporate rhodamine-labeled actin (Rd-actin)
 
1
 
 into patch-
like structures, many, but not all, of which coincide with
endogenous actin patches. The incorporation of Rd-actin
into the permeabilized yeast cells results from actin poly-
merization, and the pattern of actin assembly in vitro cor-
relates with the distribution of actin patches characteristic
of the cell cycle stage at which the cells are permeabilized
(Li et al., 1995).
Our studies were conducted mostly with small-budded
cells, a population that is undergoing polarized cell surface
growth. Permeabilized cells enriched for this population
incorporate Rd-actin preferentially into the bud (Li et al.,
1995). Rd-actin assembly in the bud is sensitive to protease
and heat treatments and therefore depends on localized
protein factors. Kinetic analysis indicated that these sites
contain an activity that reduces the lag (nucleation) phase
of actin polymerization (Li et al., 1995). This activity is not
likely to represent the elongation of endogenous filaments,
because the pattern of actin assembly in the permeabilized
cells does not always correlate with the distribution of en-
dogenous cortical actin filaments, and the assembly sites
are not blocked by cytochalasin D, a barbed end-capping
agent (Cooper, 1987). Mutations in specific cytoskeletal
proteins, such as Sla1, an SH3 domain-containing protein,
and Sla2, a protein with a talin-like domain (Holtzman et al.,
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1993), abolish actin polymerization in the permeabilized
cells (Li et al., 1995). However, it was not clear whether
these proteins are in fact components of the actin assem-
bly sites, because the effects of the mutations could be in-
direct.
In this report, we describe an in vitro reconstitution ap-
proach for identifying the components of cortical actin as-
sembly sites and for studying their activation mechanism.
Using this method, in conjunction with mutant analysis
and biochemical fractionation, we have identified two pro-
tein factors that activate the actin assembly sites in a se-
quential pathway.
 
Materials and Methods
 
Strains, Media, and Genetic Manipulations
 
Yeast strains used in this work are listed in Table I. Yeast cell culture and
genetic techniques were carried out by methods described by Sherman et al.
(1974).
 
Plasmid and Strain Construction
 
Yeast genomic DNA was prepared from strain RLY1 as described (Hoff-
man and Winston, 1987). A 2.88-kb DNA fragment containing the 
 
PCA1
 
open reading frame with 326- and 221-bp upstream and downstream se-
quences, respectively, was amplified from yeast genomic DNA by PCR.
This fragment was cut with 
 
Bam
 
HI and 
 
Xba
 
I and cloned into Bluescript
SK to yield pRL82. To construct the 
 
PCA1
 
 knock out plasmid, pRL80 was
cut with 
 
Hpa
 
I and 
 
Ppu
 
MI, removing 78% of 
 
PCA1
 
 coding region (amino
acids 22–632), blunted, and ligated with a DNA fragment containing the
 
HIS3
 
 gene, yielding pRL83. To construct a plasmid that expresses
COOH-terminal myc-tagged Pca1, a 
 
PCA1
 
 fragment containing the 326-
bp upstream sequence and the entire coding region (amino acids 1–779)
was PCR amplified from yeast genomic DNA and ligated into an in frame
 
Bam
 
HI site of pRL102, a PRS306- (Sikorski and Hieter, 1989) based vector
for COOH-terminal myc tagging (Li, 1997). The orientation of the insert
was determined, and the resulting plasmid in which the myc tag was at the
3
 
9
 
 end of 
 
PCA1
 
 was named pRL95.
To construct the 
 
D
 
pca1
 
 strain (RLY152), PRL83 was cut with 
 
Xba
 
I and
 
Bam
 
HI and transformed into a His3
 
2
 
 diploid yeast strain. The diploid was
sporulated, and the tetrads were dissected and analyzed. The tetrads
showed 2:2 segregation for the His
 
1
 
 phenotype. The 
 
D
 
pca1
 
 in the Leu
 
1
 
colonies was confirmed by both Southern hybridization analysis and PCR
analysis similar to that described for the construction of 
 
D
 
bee1
 
 (Li, 1997).
To construct the myc-Pca1–expressing strain (RLY163), pLY95 was lin-
earized by cutting in the 
 
URA3
 
 gene with 
 
Stu
 
I and transformed into
RLY148.
 
Extract Preparation
 
Yeast cells were grown to mid to late log phase in YPD. For small-scale
assays, cells were lysed by the liquid nitrogen-grinding method (Sorger
and Pelham, 1987). After the grinding step, an equal volume of UB (50 mM
KHepes, pH 7.5, 100 mM KCl, 3 mM MgCl
 
2
 
, 1 mM EGTA) supplemented
with protease inhibitors (PI), as described (Li et al., 1995), was added to
the cell homogenate, and the lysate was centrifuged at 300,000 
 
g
 
 for 60
min. The resulting high speed supernatant was usually at a concentration
of 20 mg/ml. For large-scale extract preparation, a yeast cell pellet was
washed with 10 vol of UB plus PI and resuspended in UB plus PI to 0.8 g/ml.
The cells were lysed by passing through a French Pressure Cell Press
(Aminco, Silver Springs, MD) at 1,200 psi. The lysate was centrifuged at
250,000 
 
g
 
 for 60 min to yield the high speed supernatant, usually at a con-
centration of 30–40 mg/ml.
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The preparation of small-budded permeabilized cells and rhodamine la-
beling of rabbit muscle actin were carried out as described (Li et al., 1995).
After the permeabilization by saponin, the cells were washed once with
UB plus PI. The urea or high salt treatment was carried out by incubating
the permeabilized cells in UB plus PI containing 2 M urea (Sigma Ultra
grade; Sigma Chemical Co., St. Louis, MO) or 0.5 M KCl for 30 min at
27
 
8
 
C. The urea or high salt treated cells were washed twice with UB plus PI
and then incubated with 20 
 
m
 
l extract for 30 min at 27
 
8
 
C. When ACF1 and
ACF2 (for definitions see Fig. 3 legend) were added sequentially, the cells
were first incubated with 10 
 
m
 
l of an ACF1-containing fraction for 20 min
at 27
 
8
 
C, washed with UB plus PI, and then incubated with 10 
 
m
 
l of an
ACF2-containing fraction for 30 min at 27
 
8
 
C. The cells were washed with
UB plus PI, and the Rd-actin assembly reaction was carried out for 8 min
as described (Li et al., 1995).
Fluorescence imaging was performed on a microscope (Axiophot;
Zeiss, Inc., Oberkochen, Germany) with a HB100 W/Z high pressure mer-
cury lamp and an oil immersion objective (100
 
3
 
 Plan Neofluar; Zeiss, Inc.).
Image acquisition was performed using Northern Exposure (Phase 3 Im-
aging Systems, Milford, MA). To calculate the percentage of the small-
budded cells that incorporated Rd-actin preferentially in the bud, a ran-
dom field of cells was chosen under phase, and the total number of small-
budded cells (bud size 
 
,
 
1/3 of the mother size) was counted. After switching
to the rhodamine channel, we counted, within the same field, the number
of cells in which the level of Rd-actin incorporation is higher than the
background fluorescence in the mother. For each test, usually 
 
z
 
200 cells
from 8–10 randomly chosen fields were counted. Quantification of the av-
erage fluorescence intensity in the bud in the experiment described in Fig.
2 was carried out using Metamorph 2.0 (Universal Imaging Corp., West
Chester, PA). The fluorescence level in the bud was subtracted by the flu-
orescence level in the mother (as the background). For each time point,
we measured 
 
z
 
40 cells that preferentially incorporated Rd-actin into the
bud. These cells were first randomly chosen under phase and then visual-
ized in the rhodamine channel. The average and standard deviation were
calculated from the 40 measurements.
 
Purification of Pca1
 
All of the column chromatography experiments were performed on the
BioLogic automated protein purification system (BioRad Laboratories,
Hercules, CA) at 4
 
8
 
C. 1-liter extract (15 mg/ml) from 0.4 kg of wet RLY1
cell pellet was loaded onto a 400-ml Q Sepharose column (Macro-Prep Q;
BioRad Laboratories) equilibrated with UB plus PI. The column was washed
with 2 liters UB plus PI and was eluted with an 800-ml salt gradient (0.1–
0.25 M KCl in UB plus PI) at a flow rate of 4 ml/min. A small amount of
each fraction was desalted over Econo-Pac 10DG columns (BioRad Labo-
ratories), concentrated three- to fivefold by Centricon 10 (Amicon, Inc.,
Beverly, MA) and assayed for ACF2 activity. The fractions that contain
ACF2 activity, eluting at 0.15–0.18 M KCl, were pooled and precipitated
with 45% ammonium sulfate (Sigma Ultra grade; Sigma Chemical Co.).
The above procedure was repeated, and the resulting materials were com-
bined.
The ammonium sulfate precipitate was resuspended in and dialyzed
against UB plus PI. The protein solution was divided into 0.5-ml aliquots
and heated at 60
 
8
 
C for 10 min in a water bath. The denatured proteins
were pelleted by centrifugation at 14,000 
 
g
 
 for 10 min. The supernatant
 
Table I. Yeast Strains
 
Name Genotype Source
 
RLY1
 
MATa ura3-52 his3-
 
D
 
200 leu2-3, 112 lys2-801
 
Drubin lab
RLY148
 
MATa ura3-52 his3-
 
D
 
200 leu2-3, 112 lys2-801 
 
D
 
pca1::HIS3
 
This work
RLY157
 
MATa ura3-52 his3-
 
D
 
200 leu2-3, 112 lys2-801 
 
D
 
bee1::LEU2
 
Li, 1997
RLY160
 
MATa ura3-52 his3-
 
D
 
200 leu2-3, 112 lys2-801 
 
D
 
bee1::LEU2
 
 
 
pBEE1-myc
 
Li, 1997
RLY163
 
MATa ura3-52 his3-
 
D
 
200 leu2-3, 112 lys2-801 
 
D
 
pca1::HIS3
 
 
 
pPCA1-myc
 
This work
 
All of the above strains are congenic in S288C background. 
Lechler and Li 
 
Cortical Actin Assembly in Yeast
 
97
 
was pooled, diluted to a KCl concentration of 25 mM, and adjusted to pH
6.0 with small amounts of 0.5 M 2-(
 
N
 
-Morpholino)ethanesulfonic acid
(MES), pH 5.3. The resulting solution was passed through a 5-ml Econo-
Pac S-Sepharose column connected in series with a 5-ml Econo-Pac hep-
arin column (BioRad Laboratories) equilibrated in 25 mM MES, pH 6.0,
25 mM KCl, 1 mM EGTA, 1 mM MgCl
 
2
 
, and PI. The flow through was
collected, adjusted back to pH 7.5 with small amounts of Tris, pH 9.1, and
ammonium sulfate added to 1 M. The protein solution was loaded onto a
5-ml Econo-Pac methyl hydrophobic interaction (mHIC) column (BioRad
Laboratories) equilibrated with 1 M ammonium sulfate in UB plus PI.
ACF2 activity was eluted by a 40-ml ammonium sulfate gradient (1–0.25
M). The ACF2 peak fractions, eluting at 0.78–0.34 M, were pooled and
fractionated over a S-200 gel filtration column (Pharmacia Fine Chemi-
cals, Piscataway, NJ), where ACF2 activity elutes between 54–63 ml. The
pooled fraction was further purified two times over a Bio-Scale Q2 col-
umn (BioRad Laboratories). The major Coomassie blue-stained band
with an apparent molecular mass of 86 kD as shown in Fig. 6, was excised
from an SDS–polyacrylamide gel. Tryptic peptide mass determination and
protein identification was carried out by Protein and Peptide Group (Eu-
ropean Molecular Biology Laboratory, Heidelberg, Germany) as de-
scribed (Winter et al., 1997). The purification procedure was only used for
the identification of ACF2, because the recovery was low (
 
z
 
2 
 
m
 
g ACF2
was purified from 12 g starting protein, even though the purification was
 
.
 
20,000-fold, as estimated by comparing the specific activity of the start-
ing material with that of the final product.
Crude ACF1 fractions, which were necessary for assaying ACF2 activ-
ity, were prepared by precipitating the flow through from the Macro-Prep
Q column with 55–75% ammonium sulfate. The precipitate, which con-
tains ACF1, was dissolved in UB plus PI to 
 
z
 
30 mg/ml, desalted, ali-
quoted, and stored frozen at 
 
2
 
80
 
8
 
C.
 
Immunodepletion and Immunoblot Analysis
 
For immunodepletion of the myc-tagged Pca1 or Bee1, 40 
 
m
 
l of the rele-
vant fraction was incubated for 1 h at 4
 
8
 
C, with 20 
 
m
 
l protein A-Sepharose
beads (Pharmacia Fine Chemicals) bound with mouse anti-myc mono-
clonal antibody (ascites; Evan et al., 1985), or as a control, mouse anti-HA
monoclonal antibody (ascites; BAbCO, Richmond, CA). The supernatant
was separated from the beads by centrifugation. Immunoblot analysis was
carried out using the enhanced chemiluminescence (ECL) detection kit
(Amersham Corp., Arlington Heights, IL).
 
Results
 
Making Actin Assembly in the Permeabilized Cells 
Dependent on a Cytoplasmic Extract
 
We took a biochemical complementation strategy for iden-
tifying the functional components of actin assembly site in
permeabilized yeast cells. We first sought conditions under
which a loss of the activity can be complemented from sol-
uble cell extracts. Fractionation of the extracts would then
lead to the identification of the complementing factors.
Treatment with 2 M urea or 0.6 M KCl, mild conditions
that are likely to inactivate or dissociate some of the com-
ponents of actin assembly sites, abolishes the ability of the
permeabilized cells to assemble actin into the bud. To test
whether the loss of the assembly activity can be comple-
mented by cytosolic factors, a soluble extract was prepared
after centrifugation of cell lysates at 300,000 
 
g
 
 and was in-
cubated with cells treated with urea or KCl. The cells were
washed with the low salt buffer after the treatment. Be-
cause our goal was to identify the components of actin as-
sembly sites at the cortex rather than any soluble proteins
that can enhance actin polymerization, cells were sepa-
rated from the extract and washed with buffer before the
Rd-actin assembly reaction. As shown in Fig. 1, the extract
has the ability to restore actin assembly to the buds of the
urea-treated cells. This extract also complements the high
salt-treated cells (data not shown). The complementation
does not occur in the presence of 2 M urea or 0.6 M salt
(data not shown), suggesting that the complementing fac-
tors could be the components of the actin assembly sites
that are inactivated. The complementing activity in the ex-
tract is sensitive to trypsin or heat (70
 
8
 
C) treatments (data
not shown), indicating that the activity is dependent on
protein factors.
The localization of actin assembly in the extract comple-
mented cells is still much more favored in the buds (Fig.
1), indicating that residual factors that are not sensitive to
the urea or high salt treatment are likely to provide the
spatial cue for the reconstitution. Interestingly, if the per-
meabilized cells are treated with both 0.6 M KCl and 0.1%
Triton X-100, a concentration of Triton that alone has no
effect on the actin assembly activity, the cytoplasmic ex-
tract can no longer restore actin incorporation to the buds
(Table II). This suggests that the urea or salt-sensitive fac-
tor(s) provided by the extract are likely to interact with a
detergent-extractable membrane component. 0.1% Tri-
ton X-100 alone does not extract the membrane protein
probably due to the presence of protein complexes, as ob-
served for some of the cytoskeleton-associated membrane
proteins.
 
Quantification of the Activity that Complements the 
Urea-treated Cells
 
Since the urea treatment usually gives a more complete in-
activation of the actin assembly activity (i.e., lower back-
ground assembly), we set out to identify the factors that
can restore actin assembly in these cells. The activity that
complements the urea-treated cells is dependent on the
concentration of the extract. The effects of the extract can
Figure 1. Reconstitution of actin assembly sites in permeabilized
yeast cells. Rhodamine fluorescence images of the permeabilized
cells after Rd-actin assembly. (a) Untreated, permeabilized cells.
(b) Permeabilized cells that were treated with 2 M urea and then
incubated with the buffer. (c) Permeabilized cells that were
treated with 2 M urea and then incubated with the extract. Bar,
10 mm. 
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be quantified by measuring: (
 
a
 
) the percentage of cells that
incorporate Rd-actin preferentially into the bud; or (
 
b
 
) the
level of fluorescence incorporated into the bud over the
background fluorescence in the mother. Both quantifica-
tion methods demonstrate a dependence of the comple-
menting activity on extract concentration (Fig. 2). The con-
centration dependence curves obtained by the two methods
show a very similar linear range and plateau, indicating
that either method could be used for quantifying the com-
plementing activity. Since the first method of quantifica-
tion is the easier of the two, this method was used for rapid
determination of the activity peaks during the purification
and subsequent experiments.
 
The Complementing Activity Is Composed of Two 
Sequentially Acting Protein Factors
 
The complexity of the complementing activity was as-
sessed by fractionation of the extract on an anion exchange
column. After passing the extract through a Q-Sepharose
column, two fractions were obtained: the flow through and
the eluate with 0.5 M KCl. The fractions were desalted,
concentrated, and assayed for the ability to complement
the urea-treated cells. Neither fraction alone showed any
complementing activity, but when the urea-treated cells
were incubated with a mixture of both fractions, actin as-
sembly in the bud was fully restored, suggesting that at
least two protein factors are required for the reconstitu-
tion of the actin assembly activity (Fig. 3 
 
A
 
). For conve-
nience, the factor in the Q flow through will be referred to
as ACF1 (assembly complementing factor), and the factor
in the Q eluate will be referred to as ACF2.
ACF1 and ACF2 do not appear to exist in a stable com-
plex, as they can be separated by fractionation of the ex-
tract on a gel filtration column (data not shown). One pos-
sibility is that ACF1 and ACF2 interact sequentially with
the permeabilized cells. This possibility was tested by first
incubating the urea-treated cells with the ACF1-contain-
ing fraction, washing the cells with extract buffer, and then
incubating the cells with the ACF2-containing fraction.
Actin assembly is fully restored in urea-treated cells after
the sequential incubations (Fig. 3 
 
B
 
). However, if the cells
were incubated with ACF2 first, washed, and then incu-
bated with ACF1, actin assembly is not restored to the
urea-treated cells, suggesting that ACF1 and ACF2 act se-
quentially in a defined order. Complementation of KCl-
treated cells also depends on the same sequential incuba-
tion with ACF1 and ACF2 (data not shown).
 
Bee1 Protein Is a Component of ACF1
 
One way to rapidly identify ACF1 and ACF2 is to test
whether an extract lacking a known cortical patch compo-
nent is defective in the complementing activity. We first
tested a number of mutant extracts, including those from
 
D
 
abp1
 
 (Drubin et al., 1988), 
 
D
 
sac6
 
 (Adams et al., 1991),
 
D
 
cap2 
 
(Amatruda et al., 1992), 
 
D
 
sla1
 
, 
 
D
 
sla2
 
 (Holtzman et al.,
1993), and 
 
cdc42-1
 
 (Adams et al., 1990). All of the extracts
exhibit a wild-type level of the complementing activity, sug-
gesting that the proteins corresponding to the null muta-
tions are unlikely to be the complementing factors. Re-
cently, we cloned the gene encoding Bee1, a yeast protein
with sequence similarity to Wiskott-Aldrich syndrome pro-
tein, and constructed a strain bearing the 
 
D
 
bee1
 
 mutation
(Li, 1997). The extract prepared from 
 
D
 
bee1
 
 cells failed to
complement the urea-treated cells (Fig. 4 
 
B
 
). Bee1 protein
has a net charge of 
 
1
 
8.75 and an isoelectric point of 9.27,
properties that are consistent with the fact that ACF1
binds to a cation exchange column (S-Sepharose) but not
to anion exchange columns (Q-Sepharose).
To determine whether Bee1 is a component of ACF1,
we fractionated an extract prepared from a strain that ex-
presses the myc-tagged Bee1 (Bee1-myc) as the sole source
of Bee1 protein (Li, 1997). This strain grows at a rate com-
parable to that of the wild type. Bee1-myc binds to the Q
column because the 6 myc tags add 24 negative charges to
the protein. The Q column flow through does not contain
any Bee1-myc and is defective in ACF1 activity (Fig. 4, 
 
A
 
and 
 
B
 
). The Q column was eluted by a step gradient of
0.25 M KCl (
 
P1
 
) followed by 0.4 M KCl (
 
P2
 
). P1 contains
all of ACF2 activity, whereas P2 contains the majority of
Bee1-myc. P2 alone is not sufficient for ACF1 activity, but
when it was added back to the flow through, ACF1 was re-
constituted (Fig. 4 
 
B
 
). Depletion of Bee1-myc from P2
 
Table II. Complementation Conditions
 
Cell treatment Actin incorporation
Complementation by
the soluble extract
 
2 M Urea
 
21
 
0.6 M KCl
 
21
 
1% Tx-100
 
22
 
0.1% Tx-100
 
1
 
Not apply
0.6 M KCl 
 
12 2
 
0.1% Tx-100
Figure 2. Quantification of the activity that complements the
urea-treated cells at various extract concentrations (horizontal
axis). The complementation activity was quantified by two meth-
ods: (a) the percentage of the small budded cells that assemble
Rd-actin to a higher level in the bud than in the mother (closed
circles); (b) the average fluorescence intensity in the bud over the
background fluorescence in the mother (open squares). The error
bars are standard deviations. The fluorescence unit is arbitrary.Lechler and Li Cortical Actin Assembly in Yeast 99
eliminates the ability of this fraction to reconstitute ACF1.
This suggests that Bee1 is a component of ACF1, but an-
other factor in the flow through of the Q column is also re-
quired for this activity. We previously showed that Bee1
interacts with Sla1 (Li, 1997), but Sla1 is not the uniden-
tified factor, because Sla1 protein is not present in Q flow
through (data not shown).
We examined the order of interaction between Bee1
and the unknown ACF1 factor. As shown in Fig. 4 C, com-
plementation was most efficient when Bee1 (P2 of Bee1-
myc extract) and the fraction containing the unknown
ACF1 factor (Q flow through of Bee1-myc extract) were
added together and least efficient when the unknown fac-
tor was added before Bee1. A precise mechanistic expla-
nation for this observation will not be available until the
unknown factor is identified.
The Purification and Identification of ACF2
We devised a procedure for the purification of ACF2 by
conventional column chromatography. The column frac-
tions were assayed for ACF2 activity: the ability to restore
actin assembly to urea-treated cells when combined with an
ACF1-containing fraction. A high-speed supernatant was
first fractionated on a Q-Sepharose column to separate
ACF1 and ACF2. ACF2 eluted as a single peak at 152–182
mM KCl. The pooled ACF2 fractions were further purified
by ammonium sulfate precipitation, heat treatment, S-Sepha-
rose column, methyl-hydrophobic interaction (mHIC) col-
umn, gel filtration, and mono Q as described in Materials
and Methods. During each fractionation step, only a single
peak of ACF2 activity was detected. Fig. 5 shows the pro-
tein profiles of the peak fractions after each step. During
the mHIC step and the steps after, a protein of roughly
86 kD (p86) always cofractionated with the ACF2 activity
and was the major protein after the final step of purification.
The 86-kD protein was excised from a polyacrylamide
gel and was digested with trypsin. The resulting peptides
were analyzed by mass spectroscopy, and their molecular
weights identified one open reading frame from the yeast
genome database. The details of this protein identification
method are described in Winter et al. (1997). To show that
p86 was indeed ACF2, the corresponding gene was cloned
and a knock-out allele constructed. The extract prepared
from cells bearing the p86 knock-out mutation did not
contain any ACF2 activity (Fig. 6 B). ACF2 activity was
restored to the strain by a plasmid that expresses a myc-
tagged p86. When the myc-p86–containing extract was
fractionated over the Q-Sepharose column, ACF2 was de-
tected in the 0.4 M KCl eluate rather than in the 0.25 M
KCl eluate where ACF2 is normally detected (Fig. 6).
Again, we believe that this shift in ACF2 elution position
on the salt gradient is due to the 24 additional negative
charges in the 6 myc epitopes. Finally, depletion of myc-
p86 completely eliminates ACF2 activity from the 0.4 M
KCl eluate (Fig. 6 B). These results show that p86 is in-
deed ACF2. We have named this protein Pca1, standing
for polarized cortical actin assembly.
PCA1 Encodes a Novel Protein
Pca1 is a novel protein of 779 amino acids in length and
has a molecular mass of 88 kD. Its predicted net charges,
isoelectric point, and hydrophobicity all agree with the
chromatographic behavior of ACF2. The NH2 terminus
has two proline-rich sequences that match the SH3 do-
main-binding motifs PPxPxR/K and R/KxxPPxP (Fig. 7
A). The COOH-terminal half contains two putative pleck-
strin homology (PH) domains, the first of which matches
well with the consensus sequence derived from other
known PH domains (Fig. 7). We constructed a knock-out
allele in which 78% of the Pca1 coding sequence was re-
placed by a marker gene. Dpca1 cells grow at a wild-type
Figure 3. Sequential activation of actin assembly sites by ACF1 and ACF2. (A) An extract was fractionated over a Q-Sepharose column
to yield the flow through and the 0.5 M KCl eluate, which were subsequently desalted and concentrated. The urea-treated, permeabi-
lized cells were incubated with the flow through (a), the eluate (b), or a 1:1 mixture of the two fractions (c) before Rd-actin polymeriza-
tion. Rhodamine fluorescence images of representative groups of cells are shown. (B) The complementing factors in the flow through
and in the eluate are designated ACF1 and ACF2, respectively. The histograms show the percentages of the urea-treated cells that pref-
erentially incorporated Rd-actin into the bud after the cells were incubated with the buffer, a mixture of ACF1 and ACF2, ACF1 first
and then ACF2, or ACF2 first and then ACF1. In the latter two treatments, the cells were washed with the buffer after the incubation
with the first factor. The percentages shown are averages of the results from two experiments, and the error bars are standard deviations.
Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 100
rate and do not exhibit any apparent defects in actin orga-
nization and cell morphology (data not shown). Further
genetic analysis has indicated that this lack of phenotype is
most likely to be due to functional redundancy.
Discussion
A Biochemical Approach for Identifying the Proteins 
that Directly Control Cortical Actin Assembly
In this report, we have described an in vitro reconstitution
approach for identifying protein components required for
cortical actin assembly. Several considerations motivated
us to take on this biochemical approach. First, genetic
studies have identified a number of cortical cytoskeletal
components, but an understanding of their mechanistic
roles has been limited by lack of knowledge of their bio-
Figure 4. Bee1 is an essential component of ACF1. An extract
prepared from the wild-type (RLY1) or the Bee1-myc–express-
ing strain (RLY160) was passed over a Q-Sepharose column yield-
ing the flow through (FT). The bound proteins were eluted with
0.25 M KCl to yield P1 and then with 0.4 M KCl to yield P2. (A) Im-
munoblot analysis with a mouse anti-myc antibody showing that
Bee1-myc is mostly in P2 (a) and showing the depletion of Bee1-
myc from P2 by the anti-myc affinity beads but not by the control
anti-HA affinity beads (b). (B) The histograms show the percent-
ages of the urea-treated cells that preferentially incorporated Rd-
actin into the bud after the cells were incubated under the condi-
tions described in the table below. The cells were washed with the
buffer between the two incubation steps. The percentages shown
are averages of the results from two experiments, and the error
bars are standard deviations. wt-ext, An extract from the wild-
type strain (RLY1); Db1-ext, an extract from the Dbee1 strain
(RLY157);  Bm, the Bee1-myc–expressing strain (RLY160); HA-
dpl, after depletion with the control anti-HA affinity beads; myc-
dpl, after depletion with the anti-myc affinity beads. (C) The order
of interaction between Bee1 and the unknown ACF1 component.
The histograms show the percentages of the urea-treated cells
that preferentially incorporated Rd-actin into the bud after the
cells were incubated under the conditions described in the table
below. The cells were washed with the buffer between the two in-
cubation steps. The percentages shown are averages of the results
from four experiments, and the error bars are standard devia-
tions. The abbreviations are the same as in B.
Figure 5. Purification of ACF2. The peak fractions that con-
tained ACF2 activity after each consecutive purification step (from
left to right) were analyzed on 12.5% SDS–polyacrylamide gels.
The gels were stained with Coomassie blue and photographed.
M, protein molecular weight marker (Life Technologies, Inc.,
Gaithersburg, MD). E, the starting extract; Q, Q-Sepharose col-
umn; AS, 45% ammonium sulfate precipitation; H, heat treat-
ment at 608C; S, S-Sepharose and heparin columns (connected in
series); HI, methyl hydrophobic interaction column; GF, S-200
Gel filtration column; Q2, Bio-Scale Q2 column.Lechler and Li Cortical Actin Assembly in Yeast 101
chemical and physical interactions. Because the assembly
or activity of key cytoskeletal complexes may be cortex
dependent, it may not be possible to assay the biochemical
activities of individual components in solution. Where sim-
ilar problems have been encountered in membrane traf-
ficking studies, permeabilized cell systems have proven
useful for developing functional assays (for review see
Pryer et al., 1992). We reasoned that permeabilized yeast
cells could provide the cellular context for studying the ac-
tivity of actin assembly complexes. This is demonstrated
by the fact that neither Pca1 nor a fraction that contains
ACF1 stimulates actin polymerization in solution (data
not shown), but strong actin assembly-stimulating activity
is detected when these factors are combined with the
chemically stripped, permeabilized cells.
Second, biochemical purification can help identify func-
tionally redundant components. A striking feature of the
actin cytoskeleton is that many important functions are
carried out by redundant proteins. For example, a null mu-
tation in either of the two myosin I genes, MYO3 and
MYO5, results in a phenotype that is indistinguishable
from that of the wild type, but the double mutant exhibits
severe defects in cell growth and actin organization (Good-
son and Spudich, 1995; Goodson et al., 1996). These func-
tionally redundant genes are likely to be missed by classi-
cal genetic screens based on loss-of-function phenotypes,
and PCA1 may be such an example. We have now isolated
a number of mutations that are synthetically lethal with
PCA1 null (Hayne, C., and R. Li, unpublished result), sug-
gesting that other protein(s) can functionally substitute for
Pca1 in vivo, and the shared function is essential. Since we
only detected a single peak of ACF2 activity during each
fractionation step, these proteins may be in low abun-
dance, may not exist in the soluble extract, or may not be
active in vitro. Their identification can be accomplished by
cloning of the genes that rescue the Dpca1 synthetic lethal
mutations.
Several of the mutations, including Dsla1, Dsla2, and
cdc42-1, that we previously showed to be defective in actin
polymerization in the permeabilized cell assay (Li et al.,
1995) do not affect the assembly complementing activities
defined in this study. Two possible explanations may ac-
Figure 6. Pca1 is the protein component of ACF2. An extract
prepared from the wild-type (RLY1) or the Pca1-myc expressing
strain (RLY163) was fractionated over a Q column as described
in the legend to Fig. 4 to yield the FT, P1, and P2 fractions. (A)
Immunoblot analysis with a mouse anti-myc antibody showing
that Pca1-myc is present exclusively in P2 (a), and the depletion
of Pca1-myc from P2 by the anti-myc affinity beads but not by the
control anti-HA affinity beads (b). (B) The histograms show the
percentages of the urea-treated cells that preferentially incorpo-
rated Rd-actin into the bud after the cells were incubated in steps
under the conditions described in the table below. The percent-
ages shown are averages of the results from two experiments. wt,
the wild-type strain (RLY1); Dpca1, RLY148; Pm, the Pca1-myc
expressing strain (RLY163); HA-dpl, after depletion with the
control anti-HA affinity beads; myc-dpl, after depletion with the
anti-myc affinity beads.
Figure 7. Sequence features of Pca1 protein. (A) Amino acid se-
quence of Pca1 (these sequence data are available from Gen-
Bank/EMBL/DDBJ under accession number Z73316). The pro-
line-rich SH3 domain-interacting sequences are underlined. The
two putative PH domains are boxed. (B) Alignment of the two
putative PH domains with the PH domains of pleckstrin (Tyers
et al., 1988), Sec7 (Liu and Pohajdak, 1992), dynamin (Downing
et al., 1994), and Bee1 (Symons et al., 1996). The conserved hy-
drophobic and basic amino acids are highlighted.The Journal of Cell Biology, Volume 138, 1997 102
count for this difference. First, the proteins affected by the
above mutations may not be extracted by the mild urea
treatment. In fact, the level of Sla2 immunofluorescence
staining in the permeabilized cells does not seem to
change before and after the urea treatment (data not
shown). Cdc42, thought to be anchored in the membrane
by a COOH-terminal geranylgeranyl group (Ziman et al.,
1991), should also be resistant to the extraction. Second,
the mutations may affect a step before the ACF-depen-
dent steps in the activation of actin nucleation sites in vivo,
and the former step is not affected by the urea treatment
in wild-type permeabilized cells. Thus, the complementa-
tion assay is perhaps more direct in identifying actin as-
sembly factors than assaying actin polymerization in mu-
tant permeabilized cells.
The Role of Bee1 and Pca1 in Cortical Actin Assembly
We have identified Bee1 as one of the proteins required
for the reconstitution of actin assembly sites. We have re-
cently reported genetic and cytological studies of the in
vivo function of Bee1. Bee1 protein is localized to actin
patches, and the Dbee1 mutation disrupts cortical patch
formation, resulting in the assembly of aberrant cable-like
actin structures in the bud (Li, 1997). The results reported
here provide the biochemical evidence that a WASP fam-
ily protein is directly involved in actin polymerization at
the cell cortex.
Mutations in WASP result in severe deficiencies in
blood cell function and morphogenesis (for review see
Kirchhausen and Rosen, 1996; Remold-O’Donnell et al.,
1996). Speculations have been made on the function of
WASP family proteins based on the fact that these pro-
teins contain multiple domains for interacting with signal-
ing and cytoskeletal proteins (for review see Featherstone,
1997). The presence of these functional regions suggests
that WASP may act as a molecular scaffold that nucleates
the formation of an actin assembly complex in response to
various signaling cascades. This notion is supported by the
observation that overexpression of WASP in cultured cells
results in the formation of actin-rich foci that contain
WASP (Symons et al., 1996). Bee1 has all of the functional
domains of WASP except the Cdc42-binding domain (Sy-
mons et al., 1996). Thus, one simple model for the action
of Bee1 is that it activates or recruits a key actin nucle-
ation factor. This nucleation factor could be the unidenti-
fied ACF1 component or could be an actin assembly site
component that is resistant to the urea treatment.
The NH2-terminal half of Bee1 shows structural similar-
ity with VASP, a protein that forms a complex with profi-
lin and regulates the rate of Listeria movement, possibly
by controlling the rate of actin elongation (Smith et al.,
1996). Both proteins contain an NH2-terminal domain with
sequence similarity to WASP homology domain 1 (WH1;
Symons et al., 1996). This domain in VASP and Bee1, as
well as in WASP, are followed by the G/APPPPP se-
quences that bind profilin (Reinhard et al., 1995; South-
wick and Purich, 1995). This structural similarity, together
with our identification of Bee1 as an actin assembly factor,
suggests that a common function could be shared by
VASP and WASP family proteins.
Since Pca1 must be supplied together with or after Bee1,
it might be the final limiting component or activator of the
actin assembly complex. It is interesting that both Bee1
and Pca1 contain PH domains (Fig. 7) which are phospho-
lipid-binding modules found in many signaling and cytoskel-
etal proteins (for review see Shaw, 1996). Bacterially ex-
pressed PH domain of N-WASP has been shown to bind
to phosphoinositides in vitro (Miki et al., 1996). There are
numerous examples where PH domains are required for
the localization of proteins to specific regions of the plasma
membrane (Lemmon and Ferguson, 1996; Shaw, 1996). The
interaction of Akt PH domain with phosphatidylinositol-
3,4-bisphosphate has also been shown to directly regulate
the dimerization and kinase activation of Akt (Datta et al.,
1995; Franke et al., 1996). Similarly, the PH domains in
Bee1 and Pca1 could serve as membrane anchors, could
promote a lipid-dependent interaction between Bee1 and
Pca1, or could stimulate the biochemical activity of these
proteins in actin polymerization. The involvement of phos-
phoinositides in the activation of actin assembly sites is
likely to be significant for the spatial and temporal regula-
tion of actin dynamics, because many signaling pathways
are mediated through the lipid kinases that control the
level and distribution of specific phospholipids (for review
see Carpenter and Cantley, 1996).
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